Clinical Trials Browser

Phase 2 × Interventional × Adebrelimab (SHR-1316) × Clear all

NCT07035392 2025-06-25

Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC

Phase 2 Not yet recruiting

Adebrelimab (SHR-1316)

NCT06506292 2024-07-17

A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)

Phase 2 Recruiting

Adebrelimab (SHR-1316)